Qi Jin

Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)

Y. Qi, B. Ebert, Xiaoping Su, 2022, Blood cancer journal.

Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)

Y. Qi, B. Ebert, Xiaoping Su, 2022, Blood Cancer Journal.

Clinical utility of the pan-immune-inflammation value in breast cancer patients

Y. Liu, Xiao-Dan Qi, T. Song, 2023, Frontiers in oncology.